Boldt J

Idioma: Ingles.
Referencias bibliográficas: 39
Paginas: 23-28
Archivo PDF: 67.53 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Virgilio RW, Rice C, Smith D, et al. Crystalloid vs colloid rescucitation: Is one better? Surg 1979;2:129-135.

2. Kreimeier U, Peter K. Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kid Internat 1998;53 (suppl 64):75-79.

3. Dawidson I. Fluid resuscitation of shock: current controversies. Crit Care Med 1989;17:1078-1080.

4. Prough DS, Johnston WE. Fluid restoration in septic shock: no solution yet. Anesth Analg 1989;69:699-704.

5. Vincent JL. The colloid-crystalloid controversy. Klin Wochensch 1991;69 (suppl XXVI):104-111.

6. Sibbald WJ. Fluid therapy in sepsis. In: Reinhard K, Eyrich K, Sprung C, eds. Sepsis - current perspectives in pathophysiology and therapy. Update in Intensive Care and Emergency Medicine, Vol 18. Berlin Heidelberg New York: Springer, 1994;266-273.

7. Edwards JD. A new debate: colloid versus colloid? In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin Heidelberg New York: Springer, 1994:152-164.

8. Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976;5:93-98.

9. Halmajäe H, Dahlqvist M, Walentin F. Artificial colloid in clinical practice - pros and cons. Bailliere‘s Clinical Anaesthesiology 1997:11/1:49-79.

10. Hillman K, Bishop G, Bristow P. The crystalloid versus colloid controvery: present status. Bailliere‘s Clinical Anaesthesiology 1997:11/1:1-13.

11. Stein L, Berand J, Morisette M. Pulmonary edema during volume infusion. Circulation 1975;52:483-489.

12. Funk W, Baldinger V. Microcirculatory perfusion during volume therapy. Anesthesiology 1995;82:975-982.

13. Wang P, Hauptman JG, Chaudry IH. Hemorrhage produces depression in microvascular blood flow which persist despite fluid resuscitation. Circ Shock 1990;32:307-318.

14. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001;93:405-409.

15. Morisaki H, Sibbald WJ. Issues in colloid and transfusion therapy of sepsis. In: Vincent, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin Heidelberg New York: Springer, 1993:357-372.

16. Boldt J, v Bormann B, Kling D, et al. Colloidosmotic pressure and extravascular lung water after extracorporeal circulation. Herz 1985;10:366-375.

17. Baldo-Enzi G, Baiocchi MR, Vigna G, et al. Analbuminemia: a natural model of metabolic compensatory systems. J Inher Metab Dis 1987;10:317-322.

18. Ruttmann TG, James MFM, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyetyhl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998;80:612-616.

19. Egli GA, Zollinger A, Seifert B, et al. Effects of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Bri J Anaesth 1997;78:684-689.

20. Wagner BK, D‘Amelio LF. Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids. Part 1. Clin Pharmacol 1993;12:335-346.

21. Evans PA, Glenn JR, Heptinstall S, et al. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998;81:198-292.

22. Mardel SN, Saunders FM, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998;80:204-207.

23. de Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-290.

24. Franz A, Bräunlich P, Gamsjäger T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-1407.

25. Strauss RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 1981;21:299-309.

26. Treib J, Haass A, Pindur G, et al. All medium starches are not the same: influence of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996;36:450-455.

27. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:974-983.

28. Boldt J, Müller M, Mentges D, et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998;24:28-36.

29. Shatney CH, Chaudry ICH. Hydroxethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis. Circ Shock 1984;13:21-22.

30. Fisher MM, Brady PW. Adverse reactions to plasma volume expanders. Drug Safety 1990;5:86-93.

31. Allhoff T, Lenhart FP. Severe dextran-induced anaphylayctic/anaphylactoid reaction inspite of hapten prophylaxis. Infusionsther Transfusionsmed 1993;20:301-306.

32. Laxenaire M, Charpentier C, Feldman L. Reactions anaphylactoides aux subitutes colloidaux du plasma: incidence, facteurs de risque, mecanismes. Ann Fr Anest Reanimat 1994;13:301-310.

33. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;. 342:248-249.

34. Cittanova ML, Leblanc I, Legendre Ch, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-1622.

35. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 2002;95:544-551.

36. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.

37. Vermeulen LC, Ratko MA, Estad BL, et al. A paradigm for consensus - the university hospital consortium guidelines fo the use of albumin, nonprotein colloids, and crystalloid solutions. Arch Intern Med 1995;155:373-379.

38. Webb AR. Crystalloid or colloid resuscitation. Are we any wiser? Crit Care 1999;3:R25-R28.

39. Astiz ME, Rackow EC. Crystalloid-colloid controversy revisited. Crit Care Med 1999;27:34-35.